| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.083 | 0.09 |